ArticleJournal of chemical biology2016

Combination of siRNA-directed gene silencing with epigallocatechin-3-gallate (EGCG) reverses drug resistance in human breast cancer cells.

Mohammad Ali EsmaeiliPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.